WebJun 9, 2024 · Introduction. Since the introduction of infliximab (IFX) in 1998 for use in the treatment of Crohn’s disease (CD), and subsequent approval for use in ulcerative colitis (UC) in 2006, anti-tumor necrosis factor-alpha inhibitor (ATA) therapy has become a key component of the treatment armamentarium for moderate to severe inflammatory bowel … WebThis has led to suboptimal use of thiopurines in clinical practice. This review article discusses the clinical aspects of thiopurine use in patients with IBD with the aim of optimizing their use to full therapeutic potential. AB - Inflammatory bowel disease (IBD), once considered a disease of the Western hemisphere, has emerged as a global disease.
Clinical Guidance: Thiopurine agents for the treatment of IBD
WebKEY POINTS: Thiopurines are used to treat both Crohn’s disease and ulcerative colitis.The two medicines in this family are azathioprine (AZA) (Imuran) and 6-mercaptopurine (6-MP) (Purinthol). These medicines have been used to treat inflammatory diseases, to prevent rejection of transplants, and even to treat some cancers, for over 50 years. WebSep 6, 2024 · Thiopurines (azathioprine, mercaptopurine, thioguanine) and methotrexate are widely used in a variety of clinical management scenarios for ulcerative colitis and Crohn’s disease. With the introduction of biologic therapies over the last 2 decades, controversies have emerged as to how these immunomodulators should be used in clinical practice, … 11涓 2
Pharmacologic therapy for inflammatory bowel disease refractory …
WebWe evaluated EBV status and outcomes within our paediatric IBD population over an 8-year period; finding that 217 of 409 (53%) screened patients were seropositive for EBV at IBD diagnosis; that thiopurines were used in 189 of 217 (87%) seropositive and 159 of 192 (83%) seronegative patients (P = 0.22); and that 7 of 192 (4%) previously ... WebApr 10, 2024 · 1. Introduction. Steroids and 5-aminosalicylic acid have been the mainstays of treatment for inflammatory bowel disease (IBD). However, based on the elucidation of the pathophysiology of IBD, numerous other drugs have been developed [Citation 1].Among them, anti-tumor necrosis factor (TNF)-α antibody drugs have revolutionized IBD treatment. WebThis review summarises clinical pharmacological aspects of thiopurines in the treatment of chronic inflammatory bowel disease (IBD). Current knowledge of pharmacogenetically … 11涔 8